Clinical trials: Body Weight Control

Obesity

A Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Obesity

• Completed
• Age: 18 to 75 years
• Phase 2
• Results posted

The purpose of this clinical trial is to learn about the safety and effects of the study medicine (called PF-06882961) for the potential treatment of obesity.

Trial name

NCT04707313

Testing

PF-06882961 (Cohorts 1 and 2), PF-06882961 (Cohort 3)

Where

41 sites in United States, Canada and 2 more

Volunteers

628 people

Sponsor

Pfizer